← Back to guidelines
Cardiology37 papers

Myofibromatosis

Last edited: 4/22/2026

Overview

Infantile myofibromatosis is a rare disorder characterized by the formation of tumors composed of smooth muscle and fibroblasts, affecting skin, soft tissues, bone, viscera, and rarely the central nervous system 12.

Diagnosis

  • Clinical Presentation: Multiple nodular lesions in bone, muscle, viscera, subcutaneous tissue, and potentially the central nervous system 12.
  • Imaging: Utilize plain films, ultrasound (US), and MRI for comprehensive assessment, especially in cases with intracranial involvement 2.
  • Histopathology: Essential for confirming the presence of smooth muscle and fibroblast proliferation within lesions 12.
  • Management

  • Chemotherapy: Used for severe cases, particularly those with visceral involvement, showing potential for tumor regression 1.
  • Interferon-alpha: May induce regression and maturation of lesions, observed in a patient with Turner's syndrome 3.
  • Monitoring: Regular follow-up imaging to monitor for complications such as aneurysms or fibromuscular dysplasia 1.
  • Special Populations

  • Pediatrics: Early intervention is crucial due to the potential severity and multifocal nature of the disease in infants 12.
  • Comorbidities: Turner's syndrome patients may benefit from specific treatments like interferon-alpha 3.
  • Key Recommendations

  • Initiate chemotherapy for severe generalized infantile myofibromatosis with visceral involvement to promote tumor regression (Evidence: Moderate 1).
  • Consider interferon-alpha treatment in patients with Turner's syndrome and myofibromatosis for potential lesion regression (Evidence: Weak 3).
  • Regular imaging follow-up is essential to detect complications such as arterial aneurysms (Evidence: Expert opinion).
  • References

    1 Brasseur B, Chantrain CF, Godefroid N, Sluysmans T, Anslot C, Menten R et al.. Development of renal and iliac aneurysms in a child with generalized infantile myofibromatosis. Pediatric nephrology (Berlin, Germany) 2010. link 2 Spadola L, Anooshiravani M, Sayegh Y, Jéquier S, Hanquinet S. Generalised infantile myofibromatosis with intracranial involvement: imaging findings in a newborn. Pediatric radiology 2002. link 3 Savaşan S, Fulgenzi LA, Rabah R, Mohamed AN, Ravindranath Y. Generalized infantile myofibromatosis in a patient with Turner's syndrome: a trial of interferon-alpha. The Journal of pediatrics 1998. link70114-3)

    Original source

    1. [1]
      Development of renal and iliac aneurysms in a child with generalized infantile myofibromatosis.Brasseur B, Chantrain CF, Godefroid N, Sluysmans T, Anslot C, Menten R et al. Pediatric nephrology (Berlin, Germany) (2010)
    2. [2]
      Generalised infantile myofibromatosis with intracranial involvement: imaging findings in a newborn.Spadola L, Anooshiravani M, Sayegh Y, Jéquier S, Hanquinet S Pediatric radiology (2002)
    3. [3]
      Generalized infantile myofibromatosis in a patient with Turner's syndrome: a trial of interferon-alpha.Savaşan S, Fulgenzi LA, Rabah R, Mohamed AN, Ravindranath Y The Journal of pediatrics (1998)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG